LogoLogo
CtrlK
SNOMED International WebsiteSNOMED Forums
  • SNOMED CT Document Library
  • Practical Guides
  • Specifications
  • Implementation Guides
  • User Guides
  • SNOMED CT Editorial Guide
    • Introduction to Editorial Guide
    • Introduction to SNOMED CT
      • Intended Use
      • Structure of Domain Coverage
      • Knowledge Representation
      • Out of Scope
      • SNOMED CT Requirements
        • Medical Vocabularies - J. Cimino
        • Electronic Health Applications
        • Implementation and Migration
        • User Communities
        • Summary of SNOMED CT Requirements
    • Introduction to Concept Model
      • Root and Top-level Concepts
      • Attributes
      • Defining Characteristics
      • Qualifying Characteristics
    • Authoring
      • Scope
        • Adjudication for Content Requests
        • Proprietary Names and Works
        • Implementation of Brand, Trademark and Copyright
      • General Naming Conventions
        • Descriptions
          • Fully Specified Name
            • Semantic Tag
          • Preferred Term
          • Synonym
          • Definition
        • Case Significance
        • Person Naming Conventions
        • Plurals
        • Punctuation and Symbols
        • Sentence Types
        • US vs. GB English
        • Action Verbs
        • Numbers and Numeric Ranges
      • General Modeling
        • Annotations
        • Changes to Components
        • Conjunction and Disjunction
        • General Concept Inclusions - GCIs
        • Grouper Concept
        • Intermediate Primitive Concept Modeling
        • Proximal Primitive Modeling
        • Relationship Group
        • Sufficiently Defined vs Primitive Concept
        • Templates
      • Domain Specific Modeling
        • Body Structure
          • Body Structure Attributes Summary
          • Anatomical Concept Model
            • Laterality
          • Anatomical Structure Naming Conventions
            • Naming Convention for SEP Model
            • Naming Convention for Digits of Hand and Foot
          • Anatomical Structure Modeling
            • Body parts and regions
            • Cardiovascular System
            • Digestive System
            • Ear
            • Endocrine System
            • Eye
            • Genitourinary system
            • Integumentary System
            • Lymphatic, Immune, Hematologic, Hematopoietic systems
            • Musculoskeletal System
              • Anatomy relating to the spine
            • Nervous System
            • Respiratory System
          • Morphologic Abnormality Modeling
            • Abscess
            • Combining morphologies
            • Congenital anomaly
            • Creating new morphologies
            • Fracture
            • Lump and mass
            • Morphologic Abnormalities vs. Findings
            • Multiple x morphologic abnormality
            • Tumor morphology
        • Clinical Finding and Disorder
          • Clinical Finding Attributes Summary
          • Clinical Finding Defining Attributes
          • Clinical Finding and Disorder Naming Conventions
            • Lateralized Disorder Naming Conventions
          • Clinical finding and Disorder Modeling
            • Specific Clinical finding and Disorder Modeling
              • Acquired abnormality of congenital anomaly
              • Adverse reaction to X vaccine
              • Allergy to X vaccine
              • Arrhythmia
              • Bacterial disorders with organism or toxin
              • Combining Morphologic Abnormalities
              • Congenital
              • Death
              • Enteritis
              • Genetic, developmental, congenital, and physical origin
                • Co-occuring Genomic Disorders
              • Hematologic and lymphatic conditions
              • Hernia
              • Iatrogenic
              • Immune function disorders
              • Infectious vs. inflammatory
              • Ischemia
              • Lesion
              • Malformation, deformation, anomaly
              • Maternal, fetal, neonatal
              • Measurement findings
              • Mental health
              • Multisystem disorders
              • Neoplasm
              • Null values
              • Obstruction
              • Osteoarthritis
              • Overdose
              • Pneumonia vs. Pneumonitis
              • Poisoning
              • Pressure ulcer Pressure injury
              • Pulmonary embolism
              • Remission
              • Rheumatoid arthritis
              • Substance withdrawal syndrome
              • Trauma and Injury
            • Disorder Combination Modeling
            • Complication and Sequela Modeling
        • Environment and Geographical Location
        • Event
          • Event Attributes Summary
          • Event Modeling
        • Observable Entity
          • Observable Entity Attributes Summary
          • Observable Entity Defining Attributes
          • Observable Entity Naming Conventions
          • Observable Entity Modeling
            • Body temperature
            • Mass vs Weight
            • Neoplasm Observables
            • Nutritional intake observable entities
            • Observable Entity and Microbiology Test Results
            • Observable Entity Templates
            • Relationship between Observable Entities and NPU codes
            • Representing LOINC Terms with the SNOMED CT Observable Entity Model
        • Organism
          • Organism Naming Conventions
        • Pharmaceutical and Biologic Product
          • Pharmaceutical and Biologic Product and Dose Form Attributes Summary
            • International Medicinal Product Model Diagrams
            • Ingredient Count Attributes
            • Ingredient Substance Attributes
            • Ingredient Strength Attributes
            • Appendix A: Product Patterns
              • Discrete manufactured dose form; similar unit of presentation
              • Continuous presentation: Metered dose unit of presentation
              • Continuous presentation: Oral liquids designed for administration by "metered" medicine spoon
              • Continuous presentation: bounded by unit of presentation; solid dose forms
              • Continuous presentation: bounded by container; liquid dose forms
              • Continuous presentation: bounded by container; liquid/semi-solid dose forms; concentration strength
              • Continuous presentation: unbounded by container
          • Medicinal Product
            • Clinical drug
              • Clinical Drug with Discrete Dose Form
              • Clinical Drug with Continuous Dose Form
              • Specific Clinical drug modeling
                • Anhydrous
                • Prolonged-release transdermal patch
                • Sodium valproate and Valproic acid
            • Medicinal Product and Medicinal Product Forms
              • Medicinal Product containing only
              • Medicinal Product containing
              • Medicinal Product Form (MPF)
                • Medicinal Product Form containing only
                • Medicinal Product Form containing
            • Medicinal Product Groupers
              • Groupers Based on Structure
              • Groupers Based on Disposition
              • Groupers Based on Multiple Dispositions, Structures
              • Groupers Based on Infusion and or Injection
              • Groupers Based on Dose form intended site
            • Vaccine Products in the Medicinal Product Hierarchy
              • Vaccine Product Top Level Groupers
              • Vaccine Product containing Concepts
              • Vaccine Product containing only Concepts
          • Qualifier values supporting Pharmaceutical and Biologic Product
            • Pharmaceutical Dose Form
              • Pharmaceutical Dose Form Naming and Modeling Conventions
              • Pharmaceutical Dose Form Grouper Based on Intended Site
              • Pharmaceutical Dose Form Grouper Without Basic Dose Form
              • Pharmaceutical Dose Form Supporting Hierarchies
                • Basic Dose Form
                • Dose Form Administration Method
                • Dose Form Intended Site
                • Dose Form Release Characteristic
                • Dose Form Transformation
                • State of Matter
            • Type of drug preparation
            • Unit of presentation
          • National Drug Extension Model
            • Introduction
            • Real Medicinal Product (RMP)
            • Medicinal Product Precisely (MP precisely)
            • Medicinal Product Form Precisely (MPF precisely)
            • Clinical Drug (CD) with Concentration and Presentation Strengths
            • Real Clinical Drug (RCD)
            • Packaged Clinical Drug (PCD)
            • Real Packaged Clinical Drug (RPCD)
            • Combination (Real) Packaged Clinical Drugs
            • Supporting Attributes
          • Glossary for Medicinal Product
        • Physical Force
        • Physical Object
          • Physical Object Attributes Summary
          • Physical Object Defining Attributes
          • Physical Object Naming and Modeling Conventions
            • Breast Prosthesis Naming and Modeling
            • Cardiac Valve Prosthesis Naming and Modeling
            • Shunt Naming and Modeling
            • Stent Naming and Modeling
        • Procedure
          • Procedure Attributes Summary
            • Procedure Defining Attributes
              • Procedure Attributes
              • Evaluation Procedure Attributes
          • Procedure Naming Conventions
            • Chemotherapy Regime Therapy Naming Conventions
            • Clinical Imaging Procedure Naming Conventions
              • Imaging Adjustments for View, Projection, or Technique
              • Diagnostic Imaging for Multiple Body Sites
              • Nuclear Medicine - Radionuclide Imaging
              • Multi-modality Imaging: PET, CT and SPECT, CT
              • Single Photon Emission Computed Tomography - SPECT
              • Positron Emission Tomography - PET
              • Fluoroscopy and Fluoroscopic Imaging
              • Imaging Guided Procedure Naming
              • Contrast for Imaging
              • Magnetic Resonance Imaging - MRI
              • Computed Tomography - CT
              • Ultrasonography
              • Radiographic Imaging, X-ray and Plain X-ray
            • Lateralized Procedure Naming Conventions
          • Procedure Modeling
            • Aspiration
              • Centesis
            • Diathermy
            • Division, lysis, transection, bisection
            • Duplex ultrasonography, Doppler ultrasound, and Doppler ultrasonography
            • Encounter
            • Endoscopy and endoscopic procedures
            • Excision, incision, biopsy
            • Flap procedures
            • Grafting
            • Imaging
            • Imaging-guided procedure modeling
            • Immunization and vaccination
            • Monitoring
            • Procedure during period of life
            • Prosthetic arthroplasty of joint
            • Regimes and therapies
            • Revision
            • Skeletal system
            • Surgical procedures
              • Surgical repair
              • Surgical vs. non-surgical
            • Transplantation
        • Qualifier Value
          • Disposition
          • International System of Units - derived unit of volume
          • International System of Units - unit of mass
          • Technique
        • Record Artifact
        • Situation with Explicit Context
          • Situation with Explicit Context Attributes Summary
          • Situation with Explicit Context Defining Attributes
          • Situation with Explicit Context Naming Conventions
          • Situation with Explicit Context Modeling
        • SNOMED CT Model Component
        • Social Context
        • Special Concept
        • Specimen
          • Specimen Attributes Summary
          • Specimen Defining Attributes
        • Staging and Scales
        • Substance
          • Substance Attribute Summary
          • Substance Defining Attributes
          • Substance Naming and Modeling Conventions
            • Substance Concept General Guidelines
            • Guidelines for Substance Hierarchy Grouper Concepts
              • Restructure of the top level substances hierarchy
              • Substance Groupers Based on Structure
              • Substance Groupers Based on Disposition
              • Substance Groupers Based on Both Structure and Disposition
              • Concepts Representing a Substance or its Modifications
            • Guidelines for Specific Substance Types
              • Antibodies and antigens
              • Antivenom
              • Autoantibody
              • Conjugate acids, bases and salts
              • Deoxyribonucleic acid and ribonucleic acid
              • Edible substances
              • Flap substances
              • Fractionated and unfractionated substances
              • Hydrates and anhydrous substances
              • Ions and electrolyte substances
              • Isomers
              • Metabolites
              • Radioactive substances
              • Saturated or unsaturated substances
              • Substances specifying a source or origin
              • Substances specifying bound
              • Substances specifying free or unbound or unconjugated
              • Substances specifying intact, fragment or subunit
              • Substances specifying physical state or physical form
          • Supporting hierarchy - Disposition
Powered by GitBook
On this page
  1. SNOMED CT Editorial Guide
  2. Authoring
  3. Domain Specific Modeling
  4. Observable Entity
  5. Observable Entity Modeling

Observable Entity Templates

Templates are available for modeling quality observables and for process observables:

  • Simple template for Quality Observable (observable entity) - v2.0

  • Simple template for Process Observable (observable entity) - v3.0

    • A nutritional intake (observable entity) - v3.0

  • Susceptibility Observable (observable entity) - v2.0

    • The Susceptibility template is a disposition observable; there is no simple template at this time.

Provide Feedback

PreviousObservable Entity and Microbiology Test ResultsNextRelationship between Observable Entities and NPU codes

Last updated 8 hours ago

Copyright © 2025 SNOMED International